96 related articles for article (PubMed ID: 335687)
1. [Combined treatment with beta-receptor blocker pindolol and diureticum trichlormethiazidum in patients with essential hypertony in stadium II WHO (author's transl))].
Zdichynec B
Z Kardiol; 1977 Sep; 66(9):508-10. PubMed ID: 335687
[TBL] [Abstract][Full Text] [Related]
2. Twice-daily pindolol and alprenolol in essential hypertension of moderate severity.
Hartikainen M; Heikkilä J
Ann Clin Res; 1976 Apr; 8(2):85-92. PubMed ID: 779590
[TBL] [Abstract][Full Text] [Related]
3. [Potassium metabolism in combined administration of pindolol and clopamide in long-term treatment of hypertension (author's transl)].
Faupel RP; Gotzen R
Dtsch Med Wochenschr; 1978 Oct; 103(41):1602-5. PubMed ID: 100301
[TBL] [Abstract][Full Text] [Related]
4. Comparison of ketanserin and pindolol in hypertension.
Gordin A; Saraste K; Turanlahti M; Sundberg S
J Hypertens Suppl; 1986 Apr; 4(1):S61-2. PubMed ID: 2939214
[TBL] [Abstract][Full Text] [Related]
5. Treatment of essential hypertension with pindolol and clopamide: problems arising from a combined beta blocker and diuretic therapy.
Rosenfeld JB; Traub YM; Cohen L
Curr Ther Res Clin Exp; 1974 Aug; 16(8):786-97. PubMed ID: 4217245
[No Abstract] [Full Text] [Related]
6. [Beta-blockader, pindolol, in the therapy of angina pectoris; a report on a multicentric controlled study].
Lang E; Fitscha P; Schiess W
Wien Med Wochenschr; 1979 Sep; 129(17):484-8. PubMed ID: 120078
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy of essential hypertension with pindolol (Visken) and hydralazine.
Persson I
Adv Clin Pharmacol; 1976; 11():1114-8. PubMed ID: 802071
[TBL] [Abstract][Full Text] [Related]
8. [Antihypertensive therapy with a new beta-blocking agent Timolol. Double blind study and comparison with Alprenolol and Pindolol (author's transl)].
Wessels F; Heinze A; Werth HW
Med Klin; 1977 Oct; 72(41):1689-95. PubMed ID: 335203
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of hypertension with a combination of prindolol and clopamide (author's transl)].
Gábor G; Jávor T; Szám I; Török E
MMW Munch Med Wochenschr; 1975 Nov; 117(46):1853-6. PubMed ID: 811982
[TBL] [Abstract][Full Text] [Related]
10. Labetalol and pindolol in the treatment of hypertension: a comparative study.
Romo M; Halttunen P; Saarinen P; Sarna S
Ann Clin Res; 1979 Dec; 11(6):249-52. PubMed ID: 398184
[TBL] [Abstract][Full Text] [Related]
11. [Clinical experiences with carteolol in patients with essential hypertension].
Viehmann P
Arzneimittelforschung; 1983; 33(2a):322-5. PubMed ID: 6340701
[TBL] [Abstract][Full Text] [Related]
12. [The effect of prindolol on the blood-pressure profile of hypertensives (with special consideration of response to exercise and plasma-renin activity) (author's transl)].
Dufey K; Krönig B; Fries G; Gunkel R; Walter U; Wolff HP
Dtsch Med Wochenschr; 1975 Aug; 100(35):1726-30. PubMed ID: 1157670
[TBL] [Abstract][Full Text] [Related]
13. Addition of the calcium antagonist PN 200-110 to pindolol markedly augments the antihypertensive effect in essential hypertension.
Dahlöf B; Andrén L; Eggertsen R; Jern S; Svensson A; Sievert A; Aurell M; Hansson L
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S102-4. PubMed ID: 2455104
[TBL] [Abstract][Full Text] [Related]
14. Combined effect of doxazosin and pindolol on blood pressure control and lipid concentrations in patients with essential hypertension selected from general practice. Hunter Hypertension Research Group.
J Hum Hypertens; 1992 Jun; 6(3):181-4. PubMed ID: 1352827
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of hypertension with the beta-receptor-antagonist pindolol (Viskèn). A comparison with chlorthalidone (Hygroton)].
Schaffalitzky de Muckadel ; Gyntelberg F
Ugeskr Laeger; 1973 May; 135(20):971-4. PubMed ID: 4585570
[No Abstract] [Full Text] [Related]
16. [Effect of pindolol (Visken) on blood pressure and plasma renin activity in various forms of hypertension].
Werning C; Vetter H
Adv Clin Pharmacol; 1976; 11():54-60. PubMed ID: 1032571
[TBL] [Abstract][Full Text] [Related]
17. Blood pressure reactivity in the evaluation of resting blood pressure and mood responses to pindolol and propranolol in hypertensive patients.
Potempa KM; Fogg LF; Fish AF; Kravitz HM
Heart Lung; 1993; 22(5):383-91. PubMed ID: 8226001
[TBL] [Abstract][Full Text] [Related]
18. Double-blind comparison of once-daily bopindolol and atenolol for mild-to-moderate hypertension.
Colnago R; Meregalli M; Turri D; Nazzari M; Fiorella G; Guffanti EE; Mazzola C
Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):347-52. PubMed ID: 2887520
[TBL] [Abstract][Full Text] [Related]
19. [Lowering of the blood pressure and renin suppression by beta receptor blockade with Visken in patients with borderline hypertension (author's transl)].
Werning C
Med Klin; 1973 Nov; 68(47):1559-63. PubMed ID: 4781097
[No Abstract] [Full Text] [Related]
20. Pindolol: a comparison with other antihypertensive drugs and a double-blind placebo trial.
Waal-Manning HJ; Simpson FO
N Z Med J; 1974 Aug; 80(522):151-7. PubMed ID: 4608769
[No Abstract] [Full Text] [Related]
[Next] [New Search]
